Report copyright - KEYNOTE-045: Randomized Phase 3 Trial of Pembrolizumab …stichtingduos.nl/wordpress/wp-content/uploads/pembrolizumab... · •n KEYNOTE-012, a phaseI 1b study, pembrolizumab exhibited
Please pass captcha verification before submit form